文献
J-GLOBAL ID:201702289216284450
整理番号:17A0224130
薬剤誘発性不整脈のリスク評価に関するヒトiPS細胞由来分化心筋細胞の薬理学的検討:IKr阻害剤の逆頻度依存的なfield potential duration延長作用と催不整脈マーカーの探索
Pharmacological characterization of human iPS cell-derived cardiomyocytes for assessing drug-induced, reverse use-dependent prolongation of field potential duration and pro-arrhythmic potential
著者 (44件):
YAMAMOTO Wataru
(Japan iPS Cardiac Safety Assessment (JiCSA))
,
YAMAMOTO Wataru
(Teijin Pharma Ltd.)
,
ASAKURA Keiichi
(Japan iPS Cardiac Safety Assessment (JiCSA))
,
ASAKURA Keiichi
(Nippon Shinyaku Co., Ltd.)
,
ANDO Hiroyuki
(Japan iPS Cardiac Safety Assessment (JiCSA))
,
ANDO Hiroyuki
(Japanese Safety Pharmacology Soc.)
,
ANDO Hiroyuki
(Ono Pharmaceutical Co., Ltd.)
,
TANIGUCHI Tomohiko
(Japan iPS Cardiac Safety Assessment (JiCSA))
,
TANIGUCHI Tomohiko
(Eisai Co., Ltd.)
,
OJIMA Atsuko
(Eisai Co., Ltd.)
,
UDA Takaaki
(Japan iPS Cardiac Safety Assessment (JiCSA))
,
UDA Takaaki
(Ono Pharmaceutical Co., Ltd.)
,
OSADA Tomoharu
(Japan iPS Cardiac Safety Assessment (JiCSA))
,
OSADA Tomoharu
(Japanese Safety Pharmacology Soc.)
,
OSADA Tomoharu
(LSI Medicine Corp.)
,
HAYASHI Seiji
(Japan iPS Cardiac Safety Assessment (JiCSA))
,
HAYASHI Seiji
(Japanese Safety Pharmacology Soc.)
,
HAYASHI Seiji
(Nippon Shinyaku Co., Ltd.)
,
KASAI Chieko
(Japan iPS Cardiac Safety Assessment (JiCSA))
,
KASAI Chieko
(Japanese Safety Pharmacology Soc.)
,
KASAI Chieko
(Astellas Pharma Inc.)
,
MIYAMOTO Norimasa
(Japan iPS Cardiac Safety Assessment (JiCSA))
,
MIYAMOTO Norimasa
(Eisai Co., Ltd.)
,
TASHIBU Hiroyuki
(Japan iPS Cardiac Safety Assessment (JiCSA))
,
TASHIBU Hiroyuki
(Japanese Safety Pharmacology Soc.)
,
TASHIBU Hiroyuki
(Ina Res. Inc.)
,
YOSHINAGA Takashi
(Japan iPS Cardiac Safety Assessment (JiCSA))
,
YOSHINAGA Takashi
(Japanese Safety Pharmacology Soc.)
,
YOSHINAGA Takashi
(Eisai Co., Ltd.)
,
YAMAZAKI Daiju
(Japan iPS Cardiac Safety Assessment (JiCSA))
,
YAMAZAKI Daiju
(National Inst. Health Sci.)
,
SUGIYAMA Atsushi
(Japan iPS Cardiac Safety Assessment (JiCSA))
,
SUGIYAMA Atsushi
(Japanese Safety Pharmacology Soc.)
,
SUGIYAMA Atsushi
(Toho Univ.)
,
KANDA Yasunari
(Japan iPS Cardiac Safety Assessment (JiCSA))
,
KANDA Yasunari
(National Inst. Health Sci.)
,
INUZUKA Takashi
(Japan iPS Cardiac Safety Assessment (JiCSA))
,
INUZUKA Takashi
(Pharmacological Evaluation Inst. Japan)
,
SAWADA Kohei
(Japan iPS Cardiac Safety Assessment (JiCSA))
,
SAWADA Kohei
(Japanese Safety Pharmacology Soc.)
,
SAWADA Kohei
(Eisai Co., Ltd.)
,
SEKINO Yuko
(Japan iPS Cardiac Safety Assessment (JiCSA))
,
SEKINO Yuko
(Japanese Safety Pharmacology Soc.)
,
SEKINO Yuko
(National Inst. Health Sci.)
資料名:
Journal of Toxicological Sciences
(Journal of Toxicological Sciences)
巻:
41
号:
Supplement
ページ:
S290
発行年:
2016年06月
JST資料番号:
Z0265B
ISSN:
0388-1350
資料種別:
逐次刊行物 (A)
記事区分:
会議録記事
発行国:
日本 (JPN)
言語:
英語 (EN)